CN104820051B - 一种虫草菌粉(Cs-4)及其制剂金水宝胶囊的检测方法 - Google Patents
一种虫草菌粉(Cs-4)及其制剂金水宝胶囊的检测方法 Download PDFInfo
- Publication number
- CN104820051B CN104820051B CN201510205141.1A CN201510205141A CN104820051B CN 104820051 B CN104820051 B CN 104820051B CN 201510205141 A CN201510205141 A CN 201510205141A CN 104820051 B CN104820051 B CN 104820051B
- Authority
- CN
- China
- Prior art keywords
- solution
- reference substance
- methanol
- preparation
- need testing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 241001236817 Paecilomyces <Clavicipitaceae> Species 0.000 title claims abstract description 21
- 241000190633 Cordyceps Species 0.000 title claims abstract description 17
- 239000000843 powder Substances 0.000 title claims abstract description 16
- 238000001514 detection method Methods 0.000 title claims description 17
- NEDIAPMWNCQWNW-UHFFFAOYSA-N massoia lactone Chemical compound CCCCCC1CC=CC(=O)O1 NEDIAPMWNCQWNW-UHFFFAOYSA-N 0.000 claims abstract description 84
- 239000001352 (6R)-6-pentyl-5,6-dihydropyran-2-one Substances 0.000 claims abstract description 42
- 238000000034 method Methods 0.000 claims abstract description 29
- 238000000605 extraction Methods 0.000 claims abstract description 26
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 96
- 239000000243 solution Substances 0.000 claims description 79
- 239000013558 reference substance Substances 0.000 claims description 41
- 238000012360 testing method Methods 0.000 claims description 36
- 239000006228 supernatant Substances 0.000 claims description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 15
- 239000000047 product Substances 0.000 claims description 14
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 9
- 239000000945 filler Substances 0.000 claims description 8
- 238000010829 isocratic elution Methods 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 8
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 7
- 239000000377 silicon dioxide Substances 0.000 claims description 7
- 229910019142 PO4 Inorganic materials 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 6
- 239000010452 phosphate Substances 0.000 claims description 6
- 238000010790 dilution Methods 0.000 claims description 5
- 239000012895 dilution Substances 0.000 claims description 5
- 238000003556 assay Methods 0.000 abstract description 4
- 239000012071 phase Substances 0.000 description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 239000002775 capsule Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 238000003908 quality control method Methods 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 238000000944 Soxhlet extraction Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- RZJRJXONCZWCBN-UHFFFAOYSA-N octadecane Chemical compound CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- -1 ucleosides Chemical compound 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 238000010268 HPLC based assay Methods 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical group [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- FGDQGIKMWOAFIK-UHFFFAOYSA-N acetonitrile;phosphoric acid Chemical compound CC#N.OP(O)(O)=O FGDQGIKMWOAFIK-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 229940038384 octadecane Drugs 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000009131 zhiling Substances 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510205141.1A CN104820051B (zh) | 2015-04-27 | 2015-04-27 | 一种虫草菌粉(Cs-4)及其制剂金水宝胶囊的检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510205141.1A CN104820051B (zh) | 2015-04-27 | 2015-04-27 | 一种虫草菌粉(Cs-4)及其制剂金水宝胶囊的检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104820051A CN104820051A (zh) | 2015-08-05 |
CN104820051B true CN104820051B (zh) | 2016-08-17 |
Family
ID=53730406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510205141.1A Active CN104820051B (zh) | 2015-04-27 | 2015-04-27 | 一种虫草菌粉(Cs-4)及其制剂金水宝胶囊的检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104820051B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110403927A (zh) * | 2017-07-25 | 2019-11-05 | 上海中医药大学附属曙光医院 | 5-羟基-2-癸烯酸在制备抗肝纤维化、慢性肝病、肝硬化和肝癌的药物中的应用 |
CN108693276A (zh) * | 2018-06-29 | 2018-10-23 | 江西济民可信药业有限公司 | 一种金水宝片的指纹图谱检测方法 |
CN109406673A (zh) * | 2018-11-26 | 2019-03-01 | 江西省药明扬海医药科技有限公司 | 一种金水宝胶囊的指纹图谱检测方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101073587B (zh) * | 2006-05-18 | 2012-07-04 | 天津天士力制药股份有限公司 | 一种柴胡药材的提取分离方法 |
EP2506837B1 (en) * | 2009-11-30 | 2020-07-01 | Amsilk GmbH | Spider silk particles for controlled and sustained delivery of compounds |
CN102653531B (zh) * | 2011-03-04 | 2014-08-13 | 上海爱普植物科技有限公司 | 一种马索亚内酯的合成方法 |
-
2015
- 2015-04-27 CN CN201510205141.1A patent/CN104820051B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104820051A (zh) | 2015-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104914199B (zh) | 一种中药组合物制剂中十二种成分的含量测定方法 | |
CN103323540B (zh) | 一种金水宝制剂中氨基酸的含量测定方法 | |
CN105424822B (zh) | 检测替格瑞洛中(1r,2s)‑2‑(3,4‑二氟苯基)环丙胺的方法 | |
CN103645257A (zh) | 木瓜饮片的检测方法 | |
CN104820051B (zh) | 一种虫草菌粉(Cs-4)及其制剂金水宝胶囊的检测方法 | |
CN105699500A (zh) | 一种超高效液相色谱法测定藿香正气滴丸中7种成分含量的方法 | |
CN103926332B (zh) | 一种同时测定半夏提取物中尿苷、鸟苷和腺苷含量的超高效液相色谱方法 | |
CN104764820A (zh) | 测定半夏糖浆中活性成分盐酸麻黄碱和盐酸伪麻黄碱含量的方法 | |
CN103645251B (zh) | 一种复方阿胶制剂的指纹图谱检测方法 | |
CN103592391B (zh) | 贞芪扶正制剂中特女贞苷的含量测定方法 | |
CN102670951B (zh) | 一种中药组合物中橙皮苷的含量测定方法 | |
CN109633003A (zh) | 一种测定远志中远志口山酮ⅲ和3,6,-二芥子酰基蔗糖含量的方法 | |
CN101961405B (zh) | 检测复方杜仲片中松脂醇二葡萄糖苷含量的方法 | |
CN108709949A (zh) | 一种发酵虫草菌粉Cs-4中药饮片的检测方法 | |
CN103512975A (zh) | Hplc法分析蛹虫草子实体和残基中有效物含量的方法 | |
WO2009155755A1 (zh) | 巴戟天寡糖的含量测定方法 | |
CN102706984A (zh) | 采用高效液相测定清肺消炎丸中盐酸麻黄碱含量的方法 | |
CN104007220B (zh) | 一种同时检测血浆中复方丹蒌片主要成分的方法 | |
CN110133129A (zh) | 一种发酵虫草菌粉(Cs-4)中甘露醇的检测方法 | |
CN110187022A (zh) | 一种参倍固肠胶囊中人参皂苷Re含量的测定方法 | |
CN109932437A (zh) | 一种药物组合物的检测方法 | |
CN102526128B (zh) | 一种中药灵芝颗粒及其制备方法和检测方法 | |
CN107664668A (zh) | 一种中药蜜丸中掺伪蜂蜜的检测方法 | |
CN109828040B (zh) | 墨旱莲药材uplc特征图谱的构建方法和检测方法 | |
CN102980958B (zh) | 一种检测决明子配方颗粒中大黄酚含量的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160713 Address after: 336000 Yuanzhou Jiangxi Pharmaceutical Industrial Park Applicant after: Jiangxi Yaoming Yanghai Pharmaceutical Science and Technology Co.,Ltd. Address before: 330096 No. seven, No. 888, hi tech Development Zone, Jiangxi, Nanchang Applicant before: JIANGXI JIMINKEXIN JINSHUIBAO PHARMACEUTICAL Co.,Ltd. Applicant before: JIANGXI GUOYAO PHARMACEUTICAI, LLC |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170927 Address after: 330096 No. seven, No. 888, Gaoxin Road, Nanchang hi tech Development Zone, Jiangxi Patentee after: JIANGXI JIMINKEXIN JINSHUIBAO PHARMACEUTICAL Co.,Ltd. Address before: 336000 Yuanzhou Jiangxi Pharmaceutical Industrial Park Patentee before: Jiangxi Yaoming Yanghai Pharmaceutical Science and Technology Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 330096 No. seven, No. 888, hi tech Zone, Nanchang hi tech Zone, Jiangxi Patentee after: Jiangxi Jinshuibao Pharmaceutical Co.,Ltd. Address before: 330096 No. seven, No. 888, hi tech Zone, Nanchang hi tech Zone, Jiangxi Patentee before: JIANGXI JIMINKEXIN JINSHUIBAO PHARMACEUTICAL Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A detection method of Cordyceps sinensis powder (CS-4) and its preparation Jinshuibao capsule Effective date of registration: 20211224 Granted publication date: 20160817 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: Jiangxi Jinshuibao Pharmaceutical Co.,Ltd. Registration number: Y2021980016165 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220902 Granted publication date: 20160817 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: Jiangxi Jinshuibao Pharmaceutical Co.,Ltd. Registration number: Y2021980016165 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A kind of Cordyceps fungus powder (Cs-4) and its preparation Jinshuibao capsule detection method Effective date of registration: 20220905 Granted publication date: 20160817 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: Jiangxi Jinshuibao Pharmaceutical Co.,Ltd. Registration number: Y2022980014590 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230830 Granted publication date: 20160817 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: Jiangxi Jinshuibao Pharmaceutical Co.,Ltd. Registration number: Y2022980014590 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Method for Detecting Cordyceps Fungi Powder (Cs-4) and Its Preparation Jinshuibao Capsules Effective date of registration: 20230831 Granted publication date: 20160817 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: Jiangxi Jinshuibao Pharmaceutical Co.,Ltd. Registration number: Y2023980054963 |